Yi C. Foong
Hobart, TAS, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Causal effects of multiple sclerosis therapies in left-truncated registry data.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 21, 2026
Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.
Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.
Journal: Frontiers in neurology
Published: May 16, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 28, 2026
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.
Journal: Brain : a journal of neurology
Published: March 12, 2026
Population-based Brain Templates for Ultra-Low-Field MRI.
Journal: Scientific data
Published: October 30, 2025
Biomarkers of neuroaxonal and astrocytic pathology in autoimmune encephalitis.
Journal: Brain, behavior, and immunity
Published: July 20, 2025
Should disease-modifying therapy be discontinued in older patients with stable multiple sclerosis after long-term clinical and radiological stability? No.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 26, 2025
Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 15, 2025
Long-term acceptability of MSReactor digital cognitive monitoring among people living with multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 01, 2025
Climate change and neurology: A survey of neurologists in Australia and New Zealand.
Journal: Journal of the neurological sciences
Published: January 31, 2025
Identifying distinct symptom profiles in people living with MS: Implications for quality of life and clinical care.
Journal: Multiple sclerosis and related disorders
Published: January 15, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort study.
Journal: Journal of neurology
Published: January 06, 2025
Last Updated: 09/26/2026